We believe this site might serve you best:

United States

English Continue

This country code will remain if no action is taken to change it.

Don't see your country?
Promega Corporation

MARK1 Kinase Enzyme System

See All Kinase Enzyme Systems
Recombinant full-length human MARK1 was expressed by baculovirus in Sf9 insect cells using an N-terminal GST tag. MARK1 is a member of the MARK family and is a serine/threonine-protein kinase that plays a key role in signal transduction. Due to its protein serine/threonine kinase activity, MARK1 is known to mediate phosphorylation of key proteins involved in signal transduction and cell communication. MARK1 phosphorylates microtubule-associated proteins and triggers microtubule disruption (1). Gene mutation studies performed in mice revealed that, after targeted disruption of the MARK1 ...

Expand to Read More »

  • Share
  • Print
  • Email
  • Prices valid for US customers only
Product Size Conc. Catalog # *List Price Order QTY Add to Cart
MARK1 Kinase Enzyme System
Close Window

MARK1 Kinase Enzyme System  Components

10μg
- V4028 $ 406.00 Add to cart

MARK1 Kinase Enzyme System

Close Window

MARK1 Kinase Enzyme System

 Components

1mg
- V6446 $ 5,990.00 Add to cart
ADP-Glo™ Kinase Assay + MARK1 Kinase Enzyme System
Close Window

ADP-Glo™ Kinase Assay + MARK1 Kinase Enzyme System  Components

  • MARK1 Kinase Enzyme System

    V40281 x 10μg
  • ADP-Glo™ Kinase Assay

    V91011 x 1,000 assays
1 each
- V4029 $ 808.00 Add to cart


You Also May Be Interested In

Storage Conditions

Upon receipt, centrifuge the kinase and dispense it into smaller quantities. Store the kinase at –70°C and the rest of the components at –20°C.

For product intended use please see Patents & Disclaimers tab.

Use Restrictions

V4028, V6446, V4029 For Research Use Only. Not for Use in Diagnostic Procedures.

Patents - Disclaimers

V4029 U.S. Pat. Nos. 7,083,911, 7,452,663 and 7,732,128 and other patents.

V4029 U.S. Pat. No. 7,700,310 and other patents and patents pending.

V4029 U.S. Pat. No. 7,741,067 and other patents and patents pending.

V4029 U.S. Pat. Nos. 6,602,677, 7,241,584 and 8,030,017 and other patents and patents pending.

V4029 U.S. Pat. No. 8,183,007 and other patents pending.

V4029 Licensed from Lonza Nottingham Ltd. under U.S. Pat. Nos. 6,599,711 and 6,911,319 and other pending and issued patents.

V4029 The method of recombinant expression of Coleoptera luciferase is covered by U.S. Pat. Nos. 5,583,024, 5,674,713 and 5,700,673.

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.

Scientists at Your Service

Scientists at Your Service

We offer a range of services to help you succeed using Promega technologies. From product training to set up of automated systems and development of custom applications—our scientific support goes beyond the basics.

Ask us! We are here to help you.